🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Sleep Number investor Stadium Capital pushes for board shakeup -letter

Published 09/13/2023, 07:06 AM
Updated 09/13/2023, 04:51 PM
© Reuters.
SNBR
-

By Svea Herbst-Bayliss

NEW YORK (Reuters) -Investment firm Stadium Capital Management wants to shake up the board of bed and mattress maker Sleep Number (NASDAQ:SNBR) Corp following more than a decade of poor returns, according to a letter reviewed by Reuters.

Stadium Capital, which owns roughly 9% of the Minneapolis, Minnesota-headquartered company, said Sleep Number is undervalued and not performing to its potential. In the last 52 weeks, the stock price has dropped 42%. It fell 1.54% on Wednesday to $25.56, sharply lower than during the COVID-19 pandemic when shares topped $140 a share as mattress sales surged.

Pointing to "deficiencies in the boardroom", the investment firm wrote: "We urge you to collaborate with us on a Board refresh that includes a Stadium Capital representative and other new directors with relevant expertise."

The company said its board and management team have engaged regularly with Stadium and "intend to continue that dialogue," adding it "put together a proposal that demonstrates that Sleep Number has listened closely to Stadium Capital and offered an opportunity for Stadium Capital to participate in the selection of a new independent director."

The company said it remains confident in its strategy and is focused on "continuing to strengthen its brand, culture and distinct competitive advantages to drive meaningful value for shareholders, while managing ongoing macro-environment challenges."

The board "failed to oversee accretive capital allocation, effective forecasting and a culture of strong accountability for management," the letter said.

Stadium, based in New Canaan, Connecticut, criticized the board’s decision to authorize more than $630 million in share repurchases at an average price of approximately $90 per share between 2020 and 2022.

The firm also said the board erred by mistaking a pandemic-driven increase in sales as heightened demand for wellness technology.

Stadium Capital had previously asked Sleep Number to add three new directors, including one of the firm's principals, without success.

The standoff sets the stage for a potential proxy fight, with the company's window for nominating director candidates just two months away.

"The Board, as presently constituted, includes long-tenured members who have been part of questionable decisions and would likely not fare well in a contested election next year," the letter said.

Rival mattress companies including Tempur-Sealy and Purple Innovation (NASDAQ:PRPL) have been the targets of successful activist campaigns.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.